Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

An 84-year-old man got a rare scalp condition from using imiquimod cream, which was cured with systemic steroids.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

The document suggests doctors should watch for bone marrow suppression and severe hair loss in patients treated with Azathioprine.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

TGF-β1 and TNF-α contribute to lung damage after radiation.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Common gene patterns may cause skin autoimmune diseases.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Alopecia areata involves specific immune cells, offering potential treatment targets.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Interleukin-15 can help hair growth and protect hair follicles.

Adipocytes in atopic dermatitis skin change and worsen inflammation and fibrosis.